VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KZIA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KZIAKazia Therapeutics Limited
$14.46$23M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKZIAQuarterly Financials

Kazia Therapeutics Limited (KZIA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kazia Therapeutics Limited (KZIA) quarterly income statement — complete revenue, gross profit & net income history

KZIA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16
Sales/Revenue019.71K22.29K2.48M51K0010K15.18M1.17K362.43K625.68K671.76K768.24K1.55M1.45M4.2M4.59M236.09K
Revenue Growth %-100%-99.21%445700%247999.5%---100%-100%754.7%4088.83%-99.81%-46.05%-18.56%-56.8%-46.99%-62.99%-68.4%1679.72%51.08%82.8%
Cost of Goods Sold00000000000009.85M09.84M09.85M05.78M
COGS % of Revenue-------------1466.44%-632.8%-234.49%-2448.88%
Gross Profit019.71K22.29K2.48M51K-626.2K-671.83K10K15.18M1.17K362.43K625.68K-9.18M768.24K-8.28M1.45M-5.65M4.59M-5.55M
Gross Margin %-100%100%100%100%100%--100%100%100%100%100%-1366.44%100%-532.8%100%-134.49%100%-2348.88%
Gross Profit Growth %-100%-99.21%445700%247999.5%100%100.15%-6362.04%-104.43%754.7%4088.83%-99.81%103.95%-18.56%-10.8%-46.99%-46.61%-68.4%-1.9%51.08%-4393.8%
Operating Expenses13.3M6.46M9.39M22.06M8.88M10.51M13.64M25.38M13.47M15.13M6.44M6.88M6.3M5.16M6.95M8.18M1.17M10.82M8.83M8.56M
OpEx % of Revenue-32787.16%42129.54%889.14%99999900%1051051.4%--134706.57%99.65%550008.97%1899.46%1006.91%768.5%904.08%526.1%80.61%257.58%192.61%3624.5%
Selling, General & Admin8.4M3.51M5.11M9.01M4.56M4.31M4.28M2.76M2.48M3.45M3.58M1.59M2.1M1.7M2.09M1.14M4.46M4.56M3.97M2.68M
SG&A % of Revenue-17791.53%22918.68%363.05%91113820%430648.6%--24825.82%22.7%305603.76%437.39%336.37%252.92%271.53%73.43%307.5%108.51%86.55%1134.99%
Research & Development4.9M2.96M4.28M13.05M4.33M6.2M9.36M9.18M10.99M11.68M2.86M5.3M4.2M2.77M3.71M5.08M4.7M6.26M4.88M4.88M
R&D % of Revenue-14995.63%19210.86%526.09%86554340%620402.8%--109880.75%76.95%244405.21%1462.06%670.53%411.91%482.66%326.53%324.05%148.88%106.42%2068.33%
Other Operating Expenses00000001000K000000000000
Operating Income-13.3M-4.85M-9.37M-19.58M-8.88M-10.51M-13.64M-25.38M-13.46M53.46K-6.43M-6.52M-5.67M-3.77M-5.03M-4.66M-7.7M-6.6M-4.26M-7.31M
Operating Margin %--24599.78%-42029.54%-789.14%-99999900%-1050951.4%---134606.57%0.35%-549908.97%-1799.46%-906.91%-561.11%-654.18%-299.78%-531.17%-157%-92.79%-3095.7%
Operating Income Growth %-41.98%75.24%-5.46%-86.29%34.86%58.59%-1.31%-47581.41%-109.21%100.82%-13.39%-73.02%-12.91%19.14%34.72%29.34%-80.88%9.74%15.82%-32.04%
EBITDA-13.3M-4.85M-8.43M-18.64M-7.95M-9.58M-12.7M-24.45M-12.53M776.59K-5.89M-5.98M-5.13M-3.23M-4.48M-4.12M-6.7M-5.73M-3.7M-6.97M
EBITDA Margin %--24599.78%-37836.13%-751.48%-99999900%-957525.5%---125259.46%5.12%-503569.49%-1649.86%-820.25%-480.46%-583.6%-264.73%-462.17%-136.47%-80.76%-2952.26%
EBITDA Growth %-57.72%73.99%-6.1%-94.71%37.42%60.83%-1.4%-3248.03%-112.6%112.99%-14.8%-85.27%-14.47%21.59%33.07%28.22%-80.83%17.73%22.05%-32.83%
D&A (Non-Cash Add-back)00934.71K934.29K934.71K934.26K934.74K934.71K934.71K723.14K542.17K542.17K542.17K541.72K542.28K544.96K999.94K862.59K551.68K338.63K
EBIT-13.3M-4.85M-9.37M-19.58M-8.88M-10.51M-13.64M-11.94M-13.45M55.65K-6.43M-6.52M-5.67M-3.77M-5.03M-4.66M-7.7M-6.6M-4.26M-7.31M
Net Interest Income157.97K42.08K14.33K5.55K6.45K22.42K139751.99K11.42K30.82K33.34K32.56K104.56K04.63K04.84K00
Interest Income157.97K42.08K14.33K5.55K6.45K22.42K139751.99K11.42K30.82K33.34K32.56K100K070027600
Interest Expense0000000000000-4.56K0-4.56K0-4.56K0-4.56K
Other Income/Expense979.46K-7.01M-1.22M1.49M-75.66K3.5M-85.09K13.52M-57.16K-2.45M-78.72K-213.63K-355.94K-596.43K-1.15M-1.96M7.98M-8.41K8.33K-994.34K
Pretax Income-12.32M-11.86M-10.59M-18.09M-8.96M-7.01M-13.72M-11.86M-13.52M-2.39M-6.51M-6.74M-6.03M-4.39M-6.18M-6.63M281.04K-6.62M-4.25M-8.32M
Pretax Margin %--60165.62%-47507.21%-729.14%-99999900%-701442.7%---135178.22%-15.77%-556637.44%-1858.4%-963.8%-653.62%-804.08%-426.11%19.39%-157.59%-92.61%-3524.5%
Income Tax0-1.61M-135.55K-135.45K-135.55K-135.45K-135.55K-52.11K-315.97K-335.25K-149.1K-149.1K-149.1K-148.9K-149.1K-161.52K-143.74K-133.51K-65.04K-1.14K
Effective Tax Rate %0%13.58%1.28%0.75%1.51%1.93%0.99%0.44%2.34%14.01%2.29%2.21%2.47%3.39%2.41%2.44%-51.14%2.02%1.53%0.01%
Net Income-12.32M-9.95M-10.45M-17.95M-8.82M-6.88M-13.59M-11.81M-13.2M-2.06M-6.36M-6.59M-5.88M-4.24M-6.03M-6.46M424.78K-6.49M-4.18M-8.23M
Net Margin %--50487.24%-46899.11%-723.68%-99999900%-687897.3%---132018.48%-13.56%-543894.02%-1817.26%-939.97%-631.45%-784.67%-415.72%29.31%-154.41%-91.19%-3485.6%
Net Income Growth %-17.87%44.58%-18.48%-161.01%35.05%41.76%-2.91%-473.85%-107.46%68.75%-8.2%-55.27%2.44%34.38%-1519.14%0.37%110.16%21.16%-9.1%-68.24%
Net Income (Continuing)-12.32M-10.25M-10.45M-17.95M-8.82M-6.88M-13.59M-11.81M-13.2M-2.06M-6.36M-6.59M-5.88M-4.24M-6.03M-6.46M424.78K-6.49M-4.18M-8.32M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-3.95-6.40-6.15-31.20-18.40-15.10-46.65-44.40-50.00-7.80-29.60-38.75-43.05-32.70-54.60-64.003.30-64.35-44.30-91.75
EPS Growth %35.77%79.49%66.58%-106.62%60.56%65.99%6.7%-469.23%-68.92%79.87%31.24%-18.5%21.15%48.91%-1754.55%0.54%107.45%29.86%1.77%-12.72%
EPS (Basic)-3.95-6.40-6.15-31.20-18.40-15.10-46.65-44.40-50.00-7.80-29.60-38.75-43.05-32.70-54.60-64.003.30-64.35-44.30-91.75
Diluted Shares Outstanding3.12M1.55M850.32K575.2K479.6K456K291.4K266K264K264K214.8K170.01K136.66K129.74K110.43K101.03K100.89K100.86K94.46K89.68K
Basic Shares Outstanding3.12M1.55M850.25K575.2K479.6K456K291.4K266K264K264K214.8K170.01K136.66K129.74K110.43K101.03K100.89K100.86K94.46K89.68K
Dividend Payout Ratio--------------------